The potential to grow.


Consolidate your respiratory testing today and meet your lab’s growing needs of tomorrow.


Flu A/B/RSV Paraflu 1-4


AdV/hMPV/RV SARS-CoV-2*


SARS-CoV-2/Flu A/B* SARS-CoV-2/Flu A/B/RSV†


W O M E N ’ S H E A L T H


CT/NG Mycoplasma genitalium Trichomonas vaginalis Bacterial vaginosis Candida vaginitis/ Trichomonas vaginalis


HSV 1 & 2 HPV HPV 16 18/45 Zika Virus*


I N F E C T IO U S D I SE A SE


HIV-1 Quant Dx HCV Quant Dx HBV Quant CMV Quant Flu A/B/RSV Paraflu AdV/hMPV/RV SARS-CoV-2* SARS-CoV-2/Flu A/B* SARS-CoV-2/Flu A/B/RSV†


GI Bacterial† GI Expanded Bacterial† GI Viral† GI Parasite† GBS† EBV† BKV† C. difficile† M. gen macrolide resistance† Monkeypox†


* The Aptima SARS-CoV-2, Panther Fusion SARS-CoV-2, Aptima Zika Virus and Aptima SARS-CoV-2/Flu assays have not been FDA cleared or approved: These tests have been authorized by FDA under an EUA for use by authorized laboratories; the Aptima and Panther Fusion SARS-CoV-2 assays have been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens; the Aptima Zika Virus assay has been authorized only for the detection of nucleic acid from Zika virus, not for any other viruses or pathogens; the Aptima SARS-CoV-2/ Flu assay has been authorized only for the simultaneous qualitative detection and differentiation of nucleic acid from SARS-CoV-2, influenza A virus, influenza B virus, and not for any other viruses or pathogens. The Aptima SARS-CoV-2, Panther Fusion SARS-CoV-2, and Aptima SARS-CoV-2/ Flu assays are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner. The Aptima Zika assay is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostic tests for detection of Zika virus and/or diagnosis of Zika virus infection under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.


† In development and not for sale.


ADS-03812-001 Rev. 001 © 2022 Hologic, Inc. All rights reserved. Hologic, Aptima, Panther, Panther Fusion and associated logos are trademarks and/or registered trademarks of Hologic, Inc. and/or its subsidiaries in the United States and/or other countries.

Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52